Browsing: ASXRMD

ResMed (ASX:RMD) sits at the intersection of medical devices, sleep health and digital healthcare. At the time of writing on 9 September 2026, the shares were priced at A$30.74. For investors, the more durable question is how operating growth, product adoption and portfolio execution translate into Earnings momentum over time

ResMed Inc (ASX:RMD) is a global medical device and digital health company that develops products for the diagnosis and treatment of sleep disorders and respiratory conditions. The company’s primary products include CPAP and other positive airway pressure devices used in the treatment of obstructive sleep apnea